missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ DOK1 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA519860
This item is not returnable.
View return policy
Description
In Western blot applications, this antibody detects a band at ~62kDa. A suggested positive control is Jurkat cell lysate. PA5-19860 can be used with blocking peptide PEP-0257.
DOK1 (P62dok, Docking protein 1) is believed to be a mainly cytoplasmic adaptor protein which down-regulates mitogen-activated protein kinase activation, inhibits cell proliferation and transformation, and promotes cell spreading and cell migration. DOK1 is a major substrate for many tyrosine kinases including c-kit, v-abl, vFPS, EGF, and PDGF. Upon phosphorylation by kinases, DOK1 forms a complex with ras GTPase-activating protein. Phosphorylation on tyrosine residues by the insulin receptor kinase results in the negative regulation of the insulin signaling pathway. DOK1 contains a putative pleckstrin homology domain at the amino terminus and ten PXXP SH3 recognition motifs.
Specifications
| DOK1 | |
| Polyclonal | |
| Unconjugated | |
| DOK1 | |
| AW557123; Docking protein 1; docking protein 1, 62kDa (downstream of tyrosine kinase 1); Dok; DOK 1; DOK1; Dok-1; Downstream of tyrosine kinase 1; downstream of tyrosine kinase-1; MGC117395; MGC138860; p240; p62 dok; p62(dok); p62DOK; pp62; TLP1; TP1; TROVE domain family; TROVE1; VAULT2 | |
| Rabbit | |
| Antigen Affinity Chromatography | |
| RUO | |
| 1796 | |
| Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C | |
| Liquid |
| Western Blot, Immunocytochemistry | |
| 1 mg/mL | |
| PBS with 0.02% sodium azide | |
| Q99704 | |
| DOK1 | |
| A peptide corresponding to amino acids near the carboxy terminus of human DOK1. | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction